Candel Therapeutics, Inc.
Maria Ostrovsky (General Counsel) reports CADL insider transactions
About this filing
Candel Therapeutics, Inc. (CADL) filed Form 4 (insider transaction) with the SEC on Nov 5, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Maria Ostrovsky · General Counsel
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | A · grantStock Option (Right to Buy)Footnotes F1 | +315,000 | $0.00 | $0.00 | 315,000 | Direct |
Footnotes
- F1 25% of the shares underlying this option shall vest and become exercisable on November 3, 2027, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
More CADL filings
- SC 13G/A
Filed Nov 16, 2026
- 8-K
Filed Nov 12, 2026
- 424B5
Filed Nov 12, 2026
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- 3
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.